Purple Biotech (PPBT) Depreciation Expense (2017 - 2026)
Purple Biotech (PPBT) reported Depreciation Expense of $65000.0 for Q1 2026, up 44.44% year-over-year from $45000.0 in Q1 2025, and up 22.64% quarter-over-quarter from $53000.0 in Q4 2025.
Purple Biotech (PPBT) Depreciation Expense (2017 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 10 years of Depreciation Expense data on file, last reported at $65000.0 in Q1 2026.
- Depreciation Expense for Q1 2026 came in at $65000.0, up 44.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $223000.0 (up 21.86% YoY), and the FY2025 annual result was $203000.0, up 9.14% from the prior year.
- Depreciation Expense climbed to $65000.0 in Q1 2026 per PPBT's latest filing, from $53000.0 in the prior quarter.
- Over five years, Depreciation Expense peaked at $65000.0 in Q1 2026 and troughed at $40000.0 in Q4 2024.
- A 5-year average of $50117.6 and a median of $49000.0 in 2024 frame the typical range for Depreciation Expense.
- The sharpest annual moves came in 2022 and 2026: Depreciation Expense slipped 25.4% in 2022, then jumped 44.44% in 2026.
- A 5-year view of Depreciation Expense shows it stood at $50000.0 in 2022, then declined by 4.0% to $48000.0 in 2023, then declined by 16.67% to $40000.0 in 2024, then jumped by 32.5% to $53000.0 in 2025, then grew by 22.64% to $65000.0 in 2026.
- Business Quant data shows PPBT's Depreciation Expense at $65000.0 in Q1 2026, $53000.0 in Q4 2025, and $58000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Purple Biotech | 242.86 Mn | 236.43 Mn | - | 65,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65,000.00 |
| Dec 31, 2025 | 53,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 47,000.00 |
| Mar 31, 2025 | 45,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Sep 30, 2024 | 49,000.00 |
| Jun 30, 2024 | 49,000.00 |
| Mar 31, 2024 | 48,000.00 |
| Dec 31, 2023 | 48,000.00 |
| Sep 30, 2023 | 50,000.00 |
| Jun 30, 2023 | 53,000.00 |
| Mar 31, 2023 | 46,000.00 |
| Dec 31, 2022 | 50,000.00 |
| Sep 30, 2022 | 47,000.00 |
| Jun 30, 2022 | 53,000.00 |
| Mar 31, 2022 | 51,000.00 |
| Dec 31, 2021 | 61,000.00 |
| Sep 30, 2021 | 63,000.00 |
| Jun 30, 2021 | 61,000.00 |